476 related articles for article (PubMed ID: 18005013)
21. Minimal hepatic encephalopathy and extrapyramidal signs in patients with cirrhosis.
Jover R; Compañy L; Gutiérrez A; Zapater P; Pérez-Serra J; Girona E; Aparicio JR; Pérez-Mateo M
Am J Gastroenterol; 2003 Jul; 98(7):1599-604. PubMed ID: 12873585
[TBL] [Abstract][Full Text] [Related]
22. Disruption of smooth pursuit eye movements in cirrhosis: relationship to hepatic encephalopathy and its treatment.
Montagnese S; Gordon HM; Jackson C; Smith J; Tognella P; Jethwa N; Sherratt RM; Morgan MY
Hepatology; 2005 Oct; 42(4):772-81. PubMed ID: 16175619
[TBL] [Abstract][Full Text] [Related]
23. [Optimization of therapy in patients with hepatic cirrhosis and encephalopathy].
Ivanov AG; Trusov VV
Klin Med (Mosk); 2008; 86(6):62-6. PubMed ID: 18720715
[TBL] [Abstract][Full Text] [Related]
24. The importance of bacterial infections as precipating factors of chronic hepatic encephalopathy in cirrhosis.
Strauss E; da Costa MF
Hepatogastroenterology; 1998; 45(21):900-4. PubMed ID: 9684155
[TBL] [Abstract][Full Text] [Related]
25. [Protein catabolism and malnutrition in liver cirrhosis - impact of oral nutritional therapy].
Norman K; Valentini L; Lochs H; Pirlich M
Z Gastroenterol; 2010 Jul; 48(7):763-70. PubMed ID: 20607635
[TBL] [Abstract][Full Text] [Related]
26. Hepatic encephalopathy in patients with liver cirrhosis: is there a role of malnutrition?
Kalaitzakis E; Bjornsson E
World J Gastroenterol; 2008 Jun; 14(21):3438-9. PubMed ID: 18528945
[TBL] [Abstract][Full Text] [Related]
27. Malnutrition in end stage liver disease: recommendations and nutritional support.
Tsiaousi ET; Hatzitolios AI; Trygonis SK; Savopoulos CG
J Gastroenterol Hepatol; 2008 Apr; 23(4):527-33. PubMed ID: 18397483
[TBL] [Abstract][Full Text] [Related]
28. [Hepatic encephalopathy in patients with cirrhosis: new aspects and practical recommendations].
Ditisheim S; Spahr L
Rev Med Suisse; 2010 Sep; 6(261):1667-71. PubMed ID: 20939401
[TBL] [Abstract][Full Text] [Related]
29. Night-time sleep disturbance does not correlate with neuropsychiatric impairment in patients with cirrhosis.
Montagnese S; Middleton B; Skene DJ; Morgan MY
Liver Int; 2009 Oct; 29(9):1372-82. PubMed ID: 19686311
[TBL] [Abstract][Full Text] [Related]
30. Hepatobiliary nutrition: history and future.
Dudrick SJ; Kavic SM
J Hepatobiliary Pancreat Surg; 2002; 9(4):459-68. PubMed ID: 12483268
[TBL] [Abstract][Full Text] [Related]
31. Spatio-temporal decomposition of the electroencephalogram in patients with cirrhosis.
Montagnese S; Jackson C; Morgan MY
J Hepatol; 2007 Mar; 46(3):447-58. PubMed ID: 17239476
[TBL] [Abstract][Full Text] [Related]
32. [Basics of nutrition in cirrhosis of the liver].
Mörk H
MMW Fortschr Med; 2007 Apr; 149(17):33-4. PubMed ID: 17674907
[TBL] [Abstract][Full Text] [Related]
33. Plasma gamma aminobutyric acid concentrations provide evidence of different mechanisms in the pathogenesis of hepatic encephalopathy in acute and chronic liver disease.
Levy LJ; Losowsky MS
Hepatogastroenterology; 1989 Dec; 36(6):494-8. PubMed ID: 2613171
[TBL] [Abstract][Full Text] [Related]
34. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
[TBL] [Abstract][Full Text] [Related]
35. Variations in the promoter region of the glutaminase gene and the development of hepatic encephalopathy in patients with cirrhosis: a cohort study.
Romero-Gómez M; Jover M; Del Campo JA; Royo JL; Hoyas E; Galán JJ; Montoliu C; Baccaro E; Guevara M; Córdoba J; Soriano G; Navarro JM; Martínez-Sierra C; Grande L; Galindo A; Mira E; Mañes S; Ruiz A
Ann Intern Med; 2010 Sep; 153(5):281-8. PubMed ID: 20820037
[TBL] [Abstract][Full Text] [Related]
36. [The neuropsychologic tests and the minimal hepatic encephalopathy investigations in liver cirrhotic patients].
Lin Y; Fan YP
Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):65-6. PubMed ID: 21272466
[No Abstract] [Full Text] [Related]
37. [Plasmapheresis in the treatment of hepatic coma].
Chrostek-Maj J; Wiernikowski A; Caban J; Mossor-Ostrowska J
Pol Tyg Lek; 1992 Mar 16-30; 47(11-13):257-9. PubMed ID: 1437725
[TBL] [Abstract][Full Text] [Related]
38. [Therapeutic effect of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy].
Chen MF; Li RC; Chen CH; Gao XC
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):718-9, 722. PubMed ID: 15958319
[TBL] [Abstract][Full Text] [Related]
39. [Serum concentration of zinc in patients with liver cirrhosis with and without chronic hepatic encephalopathy. Results of a prospective study].
Garcia-Compean D; Perez-Martinez C; Cuellar JA; Barragan RF; Piñeyro Lopez A
Gastroenterol Clin Biol; 1994; 18(3):295-6. PubMed ID: 7926452
[No Abstract] [Full Text] [Related]
40. Predictors of mortality in hepatic encephalopathy in acute and chronic liver disease: a preliminary observation.
Udayakumar N; Subramaniam K; Umashankar L; Verghese J; Jayanthi V
J Clin Gastroenterol; 2007; 41(10):922-6. PubMed ID: 18090162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
